Tech Company Financing Transactions

Altair Therapeutics Funding Round

Altair Therapeutics, based in San Diego, secured $17 million in funding from Domain Associates, Forward Ventures and Ionis Pharmaceuticals.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

12555 High Bluff Dr. 310
San Diego, CA 92130
USA

Phone

(858) 436-3838

Website

www.altairtherapeutics.com

Email Address

[email protected]

Overview

Altair is building a dedicated team, combining antisense drug discovery expertise with respiratory drug development expertise, to focus solely on the development and commercialization of antisense drugs for the treatment of asthma and other respiratory conditions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Joel Martin

        

Chief Financial Officer

Nicole DeBerg

        

Chief Medical Officer

Michael Hodges

        

Chief Scientific Officer

Susan Gregory

        

Browse more venture capital transactions:

Prev: 11/12/2009: Caring.com venture capital transaction
Next: 11/12/2009: Doxo venture capital transaction

Share this article

Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary